Battling CC since April
Discussion Board › Forums › Introductions! › Battling CC since April
- This topic has 5 replies, 3 voices, and was last updated 3 years ago by Adalles.
-
AuthorPosts
-
November 8, 2021 at 8:01 pm #101355AdallesSpectator
Thank you both for the thoughtful responses. A few updates on my mom:
1. Liquid biopsy indicated MSH3 mutation.
2. She was disqualified from a Keytruda trial due to high liver enzyme levels, particularly bilirubin (10 mg/dL). Doctors at City of Hope recommended Folfox to get the cancer in control and potentially a drain instead of the stents.
3. Her blood pressure and red blood cell count have been low for the past few weeks.
4. She has lost a lot of weight (50+ lbs) and her doctor has prescribed Remeron for appetite and Tramadol for pain.
5. Doctors have discussed prophylactic antibiotics but have not prescribed anything yet. Thank you for the antibiotic recommendations given. We will make sure to discuss with her doctor.
We are saddened that we cannot pursue the Keytruda trial at this time, but still hopeful as we have a couple options (Folfox and ipilimumab/nivolumab).
Thank you for your input and support!
October 23, 2021 at 12:33 pm #101335MissingmomSpectatorChemo toxicities aside, gem/cis etc. may not be used until bilirubin level drops below 2. The rational is that higher bilirubin level indicates significant bile duct obstruction, therefore chemo will accumulate in the liver and cause liver toxicity, which defeats the purpose of using them in the first place. This is what makes CC so nasty and difficult to treat. If there is no bile duct obstruction, it will be just another type of liver tumor. So the first step for those inoperable patients to get their bilirubin level down. But it is never easy to achieve that goal even with stents or external drains as they commonly lead to infections. I believe a lot of patients die from sepsis before they even receive any anti-tumor treatment at all. On the other hand, tumor grows quickly while patients await their bilirubin to go down. And they develop abscesses and ascites. So, CC patients are under the combined threats of sepsis and tumor growth, let alone other complications such as cardiovascular events, metastasis, etc. That’s why CC is called the King of all cancers, even worse than pancreatic cancer.
- This reply was modified 3 years ago by Missingmom.
October 23, 2021 at 9:35 am #101334bglassModeratorHi Missingmom,
Thank you for your detailed description of your mother’s experience battling Cholangiocarcinoma. This is very helpful, especially for patients and caregivers with similar challenges. I am so sorry you lost your mom to this cancer.
Experiences with our cancer can vary a lot from one patient to another. A tumor in a different location or with different mutations could lead to a completely different treatment plan. We have seen patients who respond well to gem-cis including some who have made it to surgery as a result of chemo. Gem-cis, however, may not be the treatment a doctor will recommend for certain patients, e.g., those with a poor health status. These are decisions experienced doctors will make based on each patient’s situation.
Also we are seeing some patients survive longer without surgery as new treatments come online. For example, I had attached an article on liver-directed treatments to an earlier posting in this chain which discusses some additional treatment options being used for unresectable patients who qualify.
One objective of any treatment for intrahepatic cholangiocarcinoma will be to preserve good functioning of the liver, which as you and Adalles both note, complicates treatment choices for patients needing stenting.
I hope you will stay connected to our community. Again, thank you for posting.
Regards, Mary
October 21, 2021 at 3:04 am #101332MissingmomSpectatorI lost my mother to CC in June. Here is my advice based on my personal caregiving experiences, my knowledge about CC, as well as my professional background in the biomedical research.
1. Having liver abscesses is not a good sign, it’s an indicator that stent is not working, I bet her blood bilirubin level is still very high. You may not have a choice but putting in external drains via PTC. However, before you do that, make sure there is absolutely no surgical resection option on the table (see #5).
2. These external drains can be very effective relieving bile duct obstruction compared to stents. But it comes with very high cost: they are painful and drastically degrade quality of life for both patient and caregiver. Leaks are common and require almost daily wound dressing change, Drain bags need to be replaced weekly and internal tubing needs to be replaced once every 4-8 weeks via the same PTC procedure under anesthesia or heavy sedation. But the worst part, as you are already aware of, is the high risks of infections. My mom got sepsis 5 days after the initial PTC procedure that sent her to ICU. She survived in the ICU, but the infection weakened her condition so severely that she declined from that point forward with no chance to bounce back. That was one of my biggest regrets: I should have pushed the IR physician to prescribe preventive antibiotics right after the initial PTC procedure. They never voluntarily prescribe them because of MRSA drug-resistant bacteria concerns. But these CC patients with stents and drains are at heightened risks of sepsis, when that happens, they will die from infection faster than cancer. So consider your mother immuno-compromised and demand Levofloxacin amd Metronidazole. I gave my mom daily low-dose Levofloxacin 250mg and if she has low fever, ramp up to 750mg to quell the fever. Any high fever is extremely dangerous and requires an ER visit to rule out sepsis. I learned my lesson the hard way. Since I put her on the daily Levofloxacin/Metronidazole regiment, my mother’s infection risks became under control.
3. Monitor CA19-9 biomarker on a weekly basis
4. Standard chemo (Gem/Cis, etc.) do not show good outcomes on CC, instead they harm patients more particularly those in poor conditions. If the liquid biopsy results show mutations that are suitable for immuno- or targeted therapies, definitely start them ASAP. If not, still ask for immuno- and targeted therapies, which generally have much lower toxicity then chemo. And they are probably the only treatment option left. I know in other countries immuno- or targeted therapies are offered to patients even if biopsy results provide no indicated mutations.
5. Resection is still the only way to potentially increase CC patients chance of survival beyond 2+ years. It’s crucial to discuss with the best surgeon at UCSF on the resectability of her tumor.
6. Watch out for her co-morbidities such as cardiovascular events. My mom had bradycardia and QT-prolongation due to the beta blockers they gave her. After I decided to pause all medications at that point, her heart conditions stabilized.
It’s a journey that is filled with agony and stress, but I never regret the hard time I spent with my mom, taking care of her because it was the last chance I could still talk to her and when she is gone, she is gone forever. I am missing her so much and when I look back, I can say I did all I could.
- This reply was modified 3 years, 1 month ago by Missingmom.
October 20, 2021 at 10:10 pm #101331bglassModeratorHi Adalles,
Welcome to our community and thank you for posting about your mom. I am sorry she received this diagnosis and that the first round of chemo did not produced the results you and she had hoped for. My fingers are crossed that the sequencing points to additional treatment options.
As her doctors have indicated, systemic options for treatment once moving on from gem-cis would include trying a different chemo. Folfox is a commonly used second-line chemo — if you search Folfox on this site you can find patient stories about this treatment. Immunotherapy treatment is a newer treatment option, and there are now targeted treatments for patients whose testing shows some of the genomic defects (mutations) seen with our cancer. Treatments in development are accessible through participation in a clinical trial. When the cancer is only present in the liver, there are some localized treatments that can be used (e.g., radiation) but your mom’s stent and infection issues might affect whether localized treatment would be effective.
I will put a link below to an article that explains the different types of localized treatments that can be used for some of our patients.
It sounds like the stent issues and frequent replacements are an ordeal for your mom. I hope her doctors are able to address any discomfort she is feeling, and that they quickly find a good treatment option to get the cancer under control. Please send us any questions you have, and keep us posted on how your mom is doing. I know how worrying and overwhelming this diagnosis can be. The Cholangiocarcinoma Foundation website also has a lot of info and resources for patients and their caregivers.
Take care, regards, Mary
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411273/
October 19, 2021 at 8:11 pm #101327AdallesSpectatorHi everyone,
I’m grateful to have found this forum. My 63 year old mom was diagnosed with intrahepatic CC in April this year. The tumor is located where the common bile duct forks in the liver, and primarily occludes her right bile duct with some occlusion on the left. Stents were placed in April. At the time, her surgeon said that the tumor was not resectable and recommended chemo to shrink it. However, her chemo start date was delayed due to multiple infections associated with blockages in the stents. She finally started chemo (gemzar/cisplatin) in June, however, scans at the end of August indicated likely metastasis within the liver and chemo was stopped. Her oncologist recommended FOLFOX or immunotherapy (nivolumab/ipilimumab) but basically told us the prognosis is very poor.
We got second opinions from City of Hope and UCSF, both of whom recommended sequencing tumor cells to see if there were any targeted therapies. We had asked her doctor to get sequencing done at the beginning of her diagnosis, but were told it would only be considered if first line treatment failed. Certainly wish we had pushed for sequencing to be done earlier. She had a liquid biopsy (blood test as opposed to tissue biopsy) yesterday and is currently awaiting sequencing results.
Complicating things, her frequent infections impede potential treatments that we can pursue. She has had her stents switched out twice in the last month (six times since April) and was hospitalized this week with scans showing liver abscesses. Her GI doctor is considering putting in an external drain instead of stents, but that runs its own risk of infection.
Anyone else battling frequent infections due to CC? Any advice on how to deal with them? Are there any other treatments options out there that people with intrahepatic CC have considered?
Thank you for your time.
-
AuthorPosts
- The forum ‘Introductions!’ is closed to new topics and replies.